-
Investors Shift Focus to Biotechnology (Imalux raised over $15 million)
Explore Article WBNS 10TV (Nov 19 2008) Funding
CLEVELAND — A Cleveland company is among those businesses reaping the benefits. Imalux specializes in OCT or Optical Coherence Tomography. "We have a clearance from the FDA to look at tissue microstructure which looks below tissue surface for potential disturbances in the skin there. Almost like an optical biopsy we call it," Baiju Shah, President of BioEnterprise, said. Imalux is among more than 80 startups under the umbrella of BioEnterprise ... (Read Full Article)
Comment on Article Mentions: Imalux Thomas F. Barnish






Recent Comments
Eric Swanson » The Evolution of Spectral Domain OCT
For more information see http://octnews.hivefire.com/entity/profile/oct-information-on-ophthalmology-website/
bernie » Morphology and Epidermal Thickness of Normal Skin Imaged by Optical Coherence Tomography.
Interesting
See all recent comments